Julie Smith

Julie Anne Smith is Chief Executive Officer & Director at Juvena Therapeutics, Inc. since 2026.
Independent Director at Exelixis, Inc. since 2016.
Independent Director at Stoke Therapeutics, Inc. since 2020.
Formerly President, Chief Executive Officer & Director at Horizon Pharmaceutical LLC from 2015 to 2016.
President & Chief Executive Officer at Raptor Pharmaceuticals, Inc. from 2015 to 2016.
President, Chief Executive Officer & Director at Nuredis, Inc. from 2017 to 2018.
Chief Executive Officer & Director at Nuvig Therapeutics, Inc. Former President, Chief Executive Officer & Director at ESCAPE Bio, Inc. from 2018 to 2022.
Director-Channel Strategy & Design at Bristol Myers Squibb Co. Director-Health & Emerging Companies Sections at Biotechnology Innovation Organization.
Independent Director at Astellas Gene Therapies, Inc. from 2016 to 2020.
Vice President-Commercial at Jazz Pharmaceuticals, Inc. from 2006 to 2008.
Vice President-Global Marketing at Genzyme General from 2001 to 2005.
Head-Operations & Business Development at Novazyme Pharmaceuticals, Inc. from 2000 to 2001.
Chief Commercial Officer & Vice President at Enobia Pharma, Inc. from 2008 to 2012.
Education includes undergraduate degree from Cornell University.